Lapatinib in the Treatment of Ductal Carcinoma in Situ of the Breast.
Phase of Trial: Phase II
Latest Information Update: 13 Jul 2015
At a glance
- Drugs Lapatinib (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 01 Sep 2010 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
- 01 Sep 2010 Additional lead trial investigator (Sunil Badve) identified as reported by ClinicalTrials.gov.
- 01 Sep 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.